-
EN
EN
Founded in 2013 and located in Guangzhou Science City, Bostal is a high-tech enterprise with first-class new drug delivery system. Bostal has developed and established the high-end technology platforms and has the technical ability to develop a variety of complex injections and oral sustained/controlled release formulations. Bostal also has varieties of R&D pipelines, which cover treatment of major diseases such as metabolic diseases, psychiatric disorders, malignant tumors, cardiovascular and cerebrovascular diseases. Bostal has over 400 employees and covered with 68,000 m² space with advanced laboratories, manufacturing sites and offices，which can provide international pharmaceutical companies with a full range of professional services for drug products development.
Read More →Longer-lasting, safer and more convenient medicines for human
Bostal possesses extensive experience in the development of immediate-release
oral dosage forms, including conventional tablets, hard capsules, soft capsules,
granules, pellet formulations, and dry suspensions. We provide end-to-end,
customized technical services, spanning from formulation and process
screening, pilot-scale scale-up, to commercial manufacturing implementation.
Bostal is a recognized leader in modified-release oral formulations, backed by
deep technological expertise and a strong track record of successful projects.
We specialize in the development and commercial-scale manufacturing of
advanced oral modified-release technologies — from matrix and osmotic
pump systems to gastroretentive, enteric-coated, and pellet-based
platforms — helping partners accelerate timelines and reduce
regulatory risk for complex oral products.
Bostal has deep expertise in long-acting and complex injectable technologies. We
have established comprehensive R&D and commercial manufacturing platforms
for a wide range of complex injectables, including long-acting injectable
microspheres, in-situ forming gels, implants, nano-injectables, suspended
crystals, liposomes, nanoparticles, and emulsions — demonstrating our
proven capabilities in developing and scaling these challenging formulations.
Bostal has established a comprehensive technology platform dedicated to the solubilization
of poorly soluble drugs. We possess deep expertise in salt formation screening, nanomilling,
solid dispersions via Hot Melt Extrusion (HME) and Spray Drying, as well as advanced
SEDDS/SMEDDS systems — enabling significant and reproducible bioavailability
enhancement for challenging drug candidates.
Bostal has developed deep expertise in topical formulations. We offer comprehensive
capabilities spanning both R&D and commercial-scale manufacturing for a wide range
of topical dosage forms, including ointments, creams, gels, and other semi-solid
preparations — enabling robust, scalable solutions that meet rigorous quality
and regulatory standards.
Bostal is dedicated to build a "one-stop" drug development and commercialization platform, and provides customers with formulation development, pharmacodynamics, toxicology, clinical, contract manufacture, registration, and a full range of professional services.
Drug Product Development
Analytical Development
Manufacture
Preclinical Study
Clinical Study
Drugs Registration
Best for You
+86 020-22017907, Business Development：+86 180 1173 5755
If you have any suggestions for our work, please contact us and we will give you feedback as soon as possible.
Address:6F, Building C1-C2, No.11 Kaiyuan Road, Guangzhou Science Park, Guangzhou High-tech Industrial Development Zones, Guangzhou, Guangdong, China(510530)
Address:No. 228 Ruixiang Road, Huangpu District, Guangzhou, Guangdong, China(510530)
Phone:+86 020-22017907, Business Development：+86 180 1173 5755
E-mail:bstpv@bostaldrug.com（Adverse Drug Report）
E-mail:BD@bostaldrug.com（Business Consult）